Agios Pharmaceuticals, Inc. (AGIO)
35.68
+0.48
(+1.36%)
USD |
NASDAQ |
Apr 06, 11:15
Agios Pharmaceuticals Total Liabilities (Quarterly) : 104.11M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly & Co. | 85.94B |
| Biogen, Inc. | 11.18B |
| Catalyst Pharmaceuticals, Inc. | 152.54M |
| Apellis Pharmaceuticals, Inc. | 705.11M |
| Alnylam Pharmaceuticals, Inc. | 4.236B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.297B |
| Shareholders Equity (Quarterly) | 1.193B |
| Debt to Equity Ratio | 0.0337 |
| Current Ratio | 11.46 |
| Net Debt Paydown Yield | 0.26% |